Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Implementation and Sustainability of a Pharmacy-Led, Hospital-Wide Bedside Medication Delivery Program: A Qualitative Process Evaluation Using RE-AIM.

Prusaczyk B, Mixon AS, Kripalani S.

Front Public Health. 2020 Jan 22;7:419. doi: 10.3389/fpubh.2019.00419. eCollection 2019.

2.

The Rural VA Multi-Center Medication Reconciliation Quality Improvement Study (R-VA-MARQUIS).

Presley CA, Wooldridge KT, Byerly SH, Aylor AR, Kaboli PJ, Roumie CL, Schnipper JL, Dittus RS, Mixon AS.

Am J Health Syst Pharm. 2020 Jan 8;77(2):128-137. doi: 10.1093/ajhp/zxz275.

PMID:
31912884
3.

Medication Discrepancies in Older Veterans Receiving Home Healthcare.

Mixon AS, Poppendeck H, Kripalani S, Speroff T, Schnelle J, Dittus R, Roumie C.

Home Healthc Now. 2020 Jan/Feb;38(1):31-39. doi: 10.1097/NHH.0000000000000818.

PMID:
31895895
4.

Organisational context of hospitals that participated in a multi-site mentored medication reconciliation quality improvement project (MARQUIS2): a cross-sectional observational study.

Stolldorf DP, Schnipper JL, Mixon AS, Dietrich M, Kripalani S.

BMJ Open. 2019 Nov 2;9(11):e030834. doi: 10.1136/bmjopen-2019-030834.

5.

"Not in my name": the anti-racist praxis of Mab Segrest & Minnie Bruce Pratt.

Mixon A.

J Lesbian Stud. 2019 Oct 17:1-15. doi: 10.1080/10894160.2019.1678964. [Epub ahead of print]

PMID:
31621537
6.

An environmental scan of medication history technician programs within the Veterans Health Administration.

Presley CA, Byerly SH, Aylor AR, Mixon AS.

Am J Health Syst Pharm. 2019 Jan 1;76(1):44-49. doi: 10.1093/ajhp/zxy005.

PMID:
31603983
7.

Design of MARQUIS2: study protocol for a mentored implementation study of an evidence-based toolkit to improve patient safety through medication reconciliation.

Mixon AS, Smith GR Jr, Mallouk M, Nieva HR, Kripalani S, Rennke S, Chu E, Sridharan A, Dalal A, Mueller S, Williams M, Wetterneck T, Stein JM, Stolldorf D, Howell E, Orav J, Labonville S, Levin B, Yoon C, Gresham M, Goldstein J, Platt S, Nyenpan C, Schnipper JL; MARQUIS2 Site Leaders; MARQUIS2 Study Group.

BMC Health Serv Res. 2019 Sep 11;19(1):659. doi: 10.1186/s12913-019-4491-5.

8.

An On-Treatment Analysis of the MARQUIS Study: Interventions to Improve Inpatient Medication Reconciliation.

Mixon AS, Kripalani S, Stein J, Wetterneck TB, Kaboli P, Mueller S, Burdick E, Nolido NV, Labonville S, Minahan JA, Orav EJ, Goldstein J, Schnipper JL.

J Hosp Med. 2019 Oct 1;14(10):614-617. doi: 10.12788/jhm.3308. Epub 2019 Aug 16.

PMID:
31433768
9.

The Challenges of Medication Reconciliation for the Medical Home.

Mixon AS, Kripalani S.

Jt Comm J Qual Patient Saf. 2019 Aug;45(8):531-533. doi: 10.1016/j.jcjq.2019.05.004. Epub 2019 Jun 22. No abstract available.

PMID:
31235407
10.

Improving Care Transitions for Hospitalized Veterans Discharged to Skilled Nursing Facilities: A Focus on Polypharmacy and Geriatric Syndromes.

Mixon AS, Yeh VM, Simmons S, Powers J, Ely EW, Schnelle J, Vasilevskis EE.

Geriatrics (Basel). 2019 Feb 9;4(1). pii: E19. doi: 10.3390/geriatrics4010019.

11.

A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial.

Vasilevskis EE, Shah AS, Hollingsworth EK, Shotwell MS, Mixon AS, Bell SP, Kripalani S, Schnelle JF, Simmons SF; Shed-MEDS Team.

BMC Health Serv Res. 2019 Mar 14;19(1):165. doi: 10.1186/s12913-019-3995-3.

12.

Health Literacy and 1-Year Mortality: Mechanisms of Association in Adults Hospitalized for Cardiovascular Disease.

Mayberry LS, Schildcrout JS, Wallston KA, Goggins K, Mixon AS, Rothman RL, Kripalani S; Vanderbilt Inpatient Cohort Study.

Mayo Clin Proc. 2018 Dec;93(12):1728-1738. doi: 10.1016/j.mayocp.2018.07.024. Epub 2018 Nov 7.

13.

Shed-MEDS: pilot of a patient-centered deprescribing framework reduces medications in hospitalized older adults being transferred to inpatient postacute care.

Petersen AW, Shah AS, Simmons SF, Shotwell MS, Jacobsen JML, Myers AP, Mixon AS, Bell SP, Kripalani S, Schnelle JF, Vasilevskis EE.

Ther Adv Drug Saf. 2018 Jun 15;9(9):523-533. doi: 10.1177/2042098618781524. eCollection 2018 Sep.

14.

Effects of a multifaceted medication reconciliation quality improvement intervention on patient safety: final results of the MARQUIS study.

Schnipper JL, Mixon A, Stein J, Wetterneck TB, Kaboli PJ, Mueller S, Labonville S, Minahan JA, Burdick E, Orav EJ, Goldstein J, Nolido NV, Kripalani S.

BMJ Qual Saf. 2018 Dec;27(12):954-964. doi: 10.1136/bmjqs-2018-008233. Epub 2018 Aug 20.

PMID:
30126891
15.

Phosphate-control adherence in hemodialysis patients: current perspectives.

Umeukeje EM, Mixon AS, Cavanaugh KL.

Patient Prefer Adherence. 2018 Jul 4;12:1175-1191. doi: 10.2147/PPA.S145648. eCollection 2018. Review.

16.

Numeracy, Health Literacy, Cognition, and 30-Day Readmissions among Patients with Heart Failure.

Sterling MR, Safford MM, Goggins K, Nwosu SK, Schildcrout JS, Wallston KA, Mixon AS, Rothman RL, Kripalani S.

J Hosp Med. 2018 Mar 1;13(3):145-151. doi: 10.12788/jhm.2932. Epub 2018 Feb 12.

17.

Finding balance: Optimizing medication prescribing in older patients.

Sponsler KC, Mixon AS.

Cleve Clin J Med. 2018 Feb;85(2):136-137. doi: 10.3949/ccjm.85a.17087. No abstract available.

18.

Benign Breast Conditions.

Bodine AM, Holahan B, Mixon A.

J Am Osteopath Assoc. 2017 Dec 1;117(12):755-760. doi: 10.7556/jaoa.2017.147. Review.

PMID:
29181518
19.

Potentially Avoidable Readmissions of Patients Discharged to Post-Acute Care: Perspectives of Hospital and Skilled Nursing Facility Staff.

Vasilevskis EE, Ouslander JG, Mixon AS, Bell SP, Jacobsen JM, Saraf AA, Markley D, Sponsler KC, Shutes J, Long EA, Kripalani S, Simmons SF, Schnelle JF.

J Am Geriatr Soc. 2017 Feb;65(2):269-276. doi: 10.1111/jgs.14557. Epub 2016 Dec 16.

20.

Care Transitions Measure and Readmissions.

Mixon AS, Kripalani S.

J Gen Intern Med. 2017 Jan;32(1):20. doi: 10.1007/s11606-016-3867-z. No abstract available.

21.

A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias.

Roy NB, Wilson EA, Henderson S, Wray K, Babbs C, Okoli S, Atoyebi W, Mixon A, Cahill MR, Carey P, Cullis J, Curtin J, Dreau H, Ferguson DJ, Gibson B, Hall G, Mason J, Morgan M, Proven M, Qureshi A, Sanchez Garcia J, Sirachainan N, Teo J, Tedgård U, Higgs D, Roberts D, Roberts I, Schuh A.

Br J Haematol. 2016 Oct;175(2):318-330. doi: 10.1111/bjh.14221. Epub 2016 Jul 19.

22.

Medications associated with geriatric syndromes and their prevalence in older hospitalized adults discharged to skilled nursing facilities.

Saraf AA, Petersen AW, Simmons SF, Schnelle JF, Bell SP, Kripalani S, Myers AP, Mixon AS, Long EA, Jacobsen JM, Vasilevskis EE.

J Hosp Med. 2016 Oct;11(10):694-700. doi: 10.1002/jhm.2614. Epub 2016 Jun 3.

23.

Geriatric Syndromes in Hospitalized Older Adults Discharged to Skilled Nursing Facilities.

Bell SP, Vasilevskis EE, Saraf AA, Jacobsen JM, Kripalani S, Mixon AS, Schnelle JF, Simmons SF.

J Am Geriatr Soc. 2016 Apr;64(4):715-22. doi: 10.1111/jgs.14035. Epub 2016 Apr 5.

24.

Understanding vaccination rates and attitudes among patients with rheumatoid arthritis.

Sandler DS, Ruderman EM, Brown T, Lee JY, Mixon A, Liss DT, Baker DW.

Am J Manag Care. 2016 Mar;22(3):161-7.

25.

Preparedness for hospital discharge and prediction of readmission.

Mixon AS, Goggins K, Bell SP, Vasilevskis EE, Nwosu S, Schildcrout JS, Kripalani S.

J Hosp Med. 2016 Sep;11(9):603-9. doi: 10.1002/jhm.2572. Epub 2016 Feb 29. Review.

26.

Medication Nonadherence Before Hospitalization for Acute Cardiac Events.

Kripalani S, Goggins K, Nwosu S, Schildcrout J, Mixon AS, McNaughton C, McDougald Scott AM, Wallston KA; Vanderbilt Inpatient Cohort Study.

J Health Commun. 2015;20 Suppl 2:34-42. doi: 10.1080/10810730.2015.1080331.

27.

Medication Discrepancies and Associated Risk Factors Identified in Home Health patients.

Hale J, Neal EB, Myers A, Wright KH, Triplett J, Brown LB, Kripalani S, Mixon AS.

Home Healthc Now. 2015 Oct;33(9):493-9. doi: 10.1097/NHH.0000000000000290.

PMID:
26418109
28.

Development of a multivariable model to predict vulnerability in older American patients hospitalised with cardiovascular disease.

Bell SP, Schnelle J, Nwosu SK, Schildcrout J, Goggins K, Cawthon C, Mixon AS, Vasilevskis EE, Kripalani S; Vanderbilt Inpatient Cohort Study.

BMJ Open. 2015 Aug 27;5(8):e008122. doi: 10.1136/bmjopen-2015-008122.

29.

Pain and Satisfaction With Pain Management Among Older Patients During the Transition From Acute to Skilled Nursing Care.

Simmons SF, Schnelle JF, Saraf AA, Simon Coelho C, Jacobsen JM, Kripalani S, Bell S, Mixon A, Vasilevskis EE.

Gerontologist. 2016 Dec;56(6):1138-1145. Epub 2015 Jul 16.

30.

Multilayered Nanoparticles for Gene Delivery Used to Reprogram Human Foreskin Fibroblasts to Neurospheres.

Pandit V, Watson A, Ren L, Mixon A, Kotha SP.

Tissue Eng Part C Methods. 2015 Aug;21(8):786-94. doi: 10.1089/ten.TEC.2014.0482. Epub 2015 Apr 28.

31.

Combinatorial therapy using negative pressure and varying lithium dosage for accelerated wound healing.

Pandit V, Nesbitt SR, Kim DY, Mixon A, Kotha SP.

J Mech Behav Biomed Mater. 2015 Apr;44:173-8. doi: 10.1016/j.jmbbm.2015.01.012. Epub 2015 Jan 24.

PMID:
25658877
32.

Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens.

Peterson JF, Kripalani S, Danciu I, Harrell D, Marvanova M, Mixon AS, Rodriguez C, Powers JS.

J Am Geriatr Soc. 2014 Nov;62(11):2148-52. doi: 10.1111/jgs.13057. Epub 2014 Nov 3.

33.

Care transitions: a leverage point for safe and effective medication use in older adults--a mini-review.

Mixon AS, Neal E, Bell S, Powers JS, Kripalani S.

Gerontology. 2015;61(1):32-40. doi: 10.1159/000363765. Epub 2014 Sep 30. Review.

34.

Characteristics associated with postdischarge medication errors.

Mixon AS, Myers AP, Leak CL, Lou Jacobsen JM, Cawthon C, Goggins KM, Nwosu S, Schildcrout JS, Schnelle JF, Speroff T, Kripalani S.

Mayo Clin Proc. 2014 Aug;89(8):1042-51. doi: 10.1016/j.mayocp.2014.04.023. Epub 2014 Jul 3.

35.

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, Hanada K, Almeida JR, Darko S, Douek DC, Yang JC, Rosenberg SA.

J Clin Invest. 2014 May;124(5):2246-59. doi: 10.1172/JCI73639. Epub 2014 Mar 25.

36.

Myosin16b: The COOH-tail region directs localization to the nucleus and overexpression delays S-phase progression.

Cameron RS, Liu C, Mixon AS, Pihkala JP, Rahn RJ, Cameron PL.

Cell Motil Cytoskeleton. 2007 Jan;64(1):19-48. Erratum in: Cell Motil Cytoskeleton. 2007 Mar;64(3):233.

PMID:
17029291
37.

Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry.

Trimpin S, Mixon AE, Stapels MD, Kim MY, Spencer PS, Deinzer ML.

Biochemistry. 2004 Feb 24;43(7):2091-105.

PMID:
14967049
38.

Proteome analysis of lens epithelia, fibers, and the HLE B-3 cell line.

Wang-Su ST, McCormack AL, Yang S, Hosler MR, Mixon A, Riviere MA, Wilmarth PA, Andley UP, Garland D, Li H, David LL, Wagner BJ.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4829-36.

PMID:
14578405
39.

Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.

Marroquin CE, Westwood JA, Lapointe R, Mixon A, Wunderlich JR, Caron D, Rosenberg SA, Hwu P.

J Immunother. 2002 May-Jun;25(3):278-88.

40.

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

Panelli MC, Wunderlich J, Jeffries J, Wang E, Mixon A, Rosenberg SA, Marincola FM.

J Immunother. 2000 Jul-Aug;23(4):487-98.

PMID:
10916759
41.

Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).

Berger AC, Alexander HR, Wu PC, Tang G, Gnant MF, Mixon A, Turner ES, Libutti SK.

Cytokine. 2000 Jul;12(7):992-1000.

PMID:
10880244
42.

Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin.

Nguyen DM, Chen A, Mixon A, Schrump DS.

J Thorac Cardiovasc Surg. 1999 Nov;118(5):908-15.

43.

NY-ESO-1 may be a potential target for lung cancer immunotherapy.

Lee L, Wang RF, Wang X, Mixon A, Johnson BE, Rosenberg SA, Schrump DS.

Cancer J Sci Am. 1999 Jan-Feb;5(1):20-5.

PMID:
10188057
44.

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.

Cormier JN, Panelli MC, Hackett JA, Bettinotti MP, Mixon A, Wunderlich J, Parker LL, Restifo NP, Ferrone S, Marincola FM.

Int J Cancer. 1999 Mar 1;80(5):781-90.

45.

Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells.

Schrump DS, Matthews W, Chen GA, Mixon A, Altorki NK.

Clin Cancer Res. 1998 Nov;4(11):2885-90.

46.

T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.

Nishimura MI, Custer MC, Schwarz SL, Parker LL, Mixon A, Clay TM, Yannelli JR, Rosenberg SA.

J Immunother. 1998 Sep;21(5):352-62.

PMID:
9789197
47.

Identification of a T-cell receptor from a therapeutic murine T-cell clone.

Shilyansky J, Yang JC, Custer MC, Spiess P, Mixon A, Cole DJ, Mulé JJ, Rosenberg SA, Nishimura MI.

J Immunother. 1997 Jul;20(4):247-55.

PMID:
9220314
48.

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

Dadmarz RD, Ordoubadi A, Mixon A, Thompson CO, Barracchini KC, Hijazi YM, Steller MA, Rosenberg SA, Schwartzentruber DJ.

Cancer J Sci Am. 1996 Sep-Oct;2(5):263-72.

PMID:
9166543
49.

Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al.

Cancer Res. 1995 Jul 15;55(14):3149-57.

50.

Helper T cells infiltrating human renal cell carcinomas have the phenotype of activated memory-like T lymphocytes.

Alexander RB, Fitzgerald EB, Mixon A, Carter CS, Jakobsen M, Cohen PA, Rosenberg SA.

J Immunother Emphasis Tumor Immunol. 1995 Jan;17(1):39-46.

PMID:
7728304

Supplemental Content

Support Center